NCT05087173

Brief Summary

To evaluate the performance of an interactive chatbot and assess its effectiveness for enhancing informed decisions made by cataract patients.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
1,200

participants targeted

Target at P75+ for not_applicable covid19

Timeline
Completed

Started Oct 2021

Longer than P75 for not_applicable covid19

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 11, 2021

Completed
9 days until next milestone

First Submitted

Initial submission to the registry

October 20, 2021

Completed
1 day until next milestone

First Posted

Study publicly available on registry

October 21, 2021

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 31, 2023

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2023

Completed
Last Updated

January 18, 2023

Status Verified

January 1, 2023

Enrollment Period

1.9 years

First QC Date

October 20, 2021

Last Update Submit

January 16, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Informed choice about COVID-19 vaccination (the proportion of participants who make an informed choice,which is defined as a good knowledge score and an intention that is consistent with their attitude score)

    Informed choice is an aggregated measure of multiple measurements, including knowledge (a 10-item questionnaire that assesses knowledge), attitudes (6 items, with 5 responses for each), and intentions (single item with 5 responses)

    2 weeks post intervention

Study Arms (1)

Interactive Q&A chatbot

EXPERIMENTAL

A chatbot of patient decision aid embedded into a mobile application which is able to bidirectionally interact with patients and provide standard general information, quantitative risk information on the possible outcomes of COVID-19 vaccination.

Device: Chatbot

Interventions

ChatbotDEVICE

An interactive chatbot for patient decision aid A chatbot of patient decision aid embedded into a mobile application which is able to bidirectionally interact with patients and provide standard general information, quantitative risk information on the possible outcomes of COVID-19 vaccination.

Interactive Q&A chatbot

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Individuals aged over 18 years who have been resident in the selected study district for more than six months;
  • Willing to participate the study and provide informed consent.

You may not qualify if:

  • Having ocular, hearing or mental disorders precluding reading or telephone interview.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Yingfeng Zheng, MD, PhD

Guangzhou, Guangdong, China

RECRUITING

MeSH Terms

Conditions

COVID-19

Condition Hierarchy (Ancestors)

Pneumonia, ViralPneumoniaRespiratory Tract InfectionsInfectionsVirus DiseasesCoronavirus InfectionsCoronaviridae InfectionsNidovirales InfectionsRNA Virus InfectionsLung DiseasesRespiratory Tract Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

October 20, 2021

First Posted

October 21, 2021

Study Start

October 11, 2021

Primary Completion

August 31, 2023

Study Completion

December 31, 2023

Last Updated

January 18, 2023

Record last verified: 2023-01

Data Sharing

IPD Sharing
Will not share

Locations